67 related articles for article (PubMed ID: 10806636)
1. Immunologic predictors of HIV-related survival among Texas prison inmates.
Baillargeon J; Grady J; Borucki MJ
AIDS Patient Care STDS; 2000 Apr; 14(4):183-7. PubMed ID: 10806636
[TBL] [Abstract][Full Text] [Related]
2. Determinants of HIV-related survival among Texas prison inmates.
Baillargeon J; Borucki M; Williamson J; Dunn K
AIDS Patient Care STDS; 1999 Jun; 13(6):355-61. PubMed ID: 10842856
[TBL] [Abstract][Full Text] [Related]
3. The infectious disease profile of Texas prison inmates.
Baillargeon J; Black SA; Leach CT; Jenson H; Pulvino J; Bradshaw P; Murray O
Prev Med; 2004 May; 38(5):607-12. PubMed ID: 15066363
[TBL] [Abstract][Full Text] [Related]
4. Immunological predictors of HIV-related survival.
Baillargeon J; Grady J; Borucki MJ
Int J STD AIDS; 1999 Jul; 10(7):467-70. PubMed ID: 10454183
[TBL] [Abstract][Full Text] [Related]
5. Antiretroviral prescribing patterns in the Texas prison system.
Baillargeon J; Borucki MJ; Zepeda S; Jenson HB; Leach CT
Clin Infect Dis; 2000 Dec; 31(6):1476-81. PubMed ID: 11096015
[TBL] [Abstract][Full Text] [Related]
6. The changing epidemiology of HIV in the criminal justice system.
Baillargeon J; Pulvino JS; Leonardson JE; Linthicum LC; Williams B; Penn J; Williams RS; Baillargeon G; Murray OJ
Int J STD AIDS; 2017 Nov; 28(13):1335-1340. PubMed ID: 28449629
[TBL] [Abstract][Full Text] [Related]
7. HIV Seroprevalence among newly incarcerated inmates in the Texas correctional system.
Wu ZH; Baillargeon J; Grady JJ; Black SA; Dunn K
Ann Epidemiol; 2001 Jul; 11(5):342-6. PubMed ID: 11399449
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy.
Torti C; Prosperi M; Motta D; Digiambenedetto S; Maggiolo F; Paraninfo G; Ripamonti D; Cologni G; Fabbiani M; Caputo SL; Sighinolfi L; Ladisa N; El-Hamad I; Quiros-Roldan E; Frank I
Clin Microbiol Infect; 2012 May; 18(5):449-58. PubMed ID: 21919996
[TBL] [Abstract][Full Text] [Related]
9. The association of psychiatric disorders and HIV infection in the correctional setting.
Baillargeon J; Ducate S; Pulvino J; Bradshaw P; Murray O; Olvera R
Ann Epidemiol; 2003 Oct; 13(9):606-12. PubMed ID: 14732299
[TBL] [Abstract][Full Text] [Related]
10. Psychiatric disorders, HIV infection and HIV/hepatitis co-infection in the correctional setting.
Baillargeon JG; Paar DP; Wu H; Giordano TP; Murray O; Raimer BG; Avery EN; Diamond PM; Pulvino JS
AIDS Care; 2008 Jan; 20(1):124-9. PubMed ID: 18278623
[TBL] [Abstract][Full Text] [Related]
11. Enrollment in outpatient care among newly released prison inmates with HIV infection.
Baillargeon JG; Giordano TP; Harzke AJ; Baillargeon G; Rich JD; Paar DP
Public Health Rep; 2010; 125 Suppl 1(Suppl 1):64-71. PubMed ID: 20408389
[TBL] [Abstract][Full Text] [Related]
12. The association of neoplasms and HIV infection in the correctional setting.
Baillargeon J; Pollock BH; Leach CT; Gao SJ
Int J STD AIDS; 2004 May; 15(5):348-51. PubMed ID: 15117507
[TBL] [Abstract][Full Text] [Related]
13. CD4+ T-lymphocyte count/CD8+ T-lymphocyte count ratio: surrogate for HIV infection in infants?
Navaneethapandian PG; Karunaianantham R; Subramanyan S; Chinnayan P; Chandrasekaran P; Swaminathan S
J Trop Pediatr; 2012 Oct; 58(5):394-7. PubMed ID: 22228820
[TBL] [Abstract][Full Text] [Related]
14. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
[TBL] [Abstract][Full Text] [Related]
15. Effect of long-term infection with nef-defective attenuated HIV type 1 on CD4+ and CD8+ T lymphocytes: increased CD45RO+CD4+ T lymphocytes and limited activation of CD8+ T lymphocytes.
Zaunders JJ; Geczy AF; Dyer WB; McIntyre LB; Cooley MA; Ashton LJ; Raynes-Greenow CH; Learmont J; Cooper DA; Sullivan JS
AIDS Res Hum Retroviruses; 1999 Nov; 15(17):1519-27. PubMed ID: 10580402
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C seroprevalence among newly incarcerated inmates in the Texas correctional system.
Baillargeon J; Wu H; Kelley MJ; Grady J; Linthicum L; Dunn K
Public Health; 2003 Jan; 117(1):43-8. PubMed ID: 12802904
[TBL] [Abstract][Full Text] [Related]
17. CD4 percentage is an independent predictor of survival in patients starting antiretroviral therapy with absolute CD4 cell counts between 200 and 350 cells/microL.
Moore DM; Hogg RS; Yip B; Craib K; Wood E; Montaner JS
HIV Med; 2006 Sep; 7(6):383-8. PubMed ID: 16903983
[TBL] [Abstract][Full Text] [Related]
18. CD4/CD8 lymphocyte counts in healthy, HIV-positive individuals & AIDS patients.
Ray K; Gupta SM; Bala M; Muralidhar S; Kumar J
Indian J Med Res; 2006 Sep; 124(3):319-30. PubMed ID: 17085836
[TBL] [Abstract][Full Text] [Related]
19. Incarceration and the acquired immunodeficiency syndrome: autopsy results in Texas prison inmates.
Gelman BB; Wolf DA; Olano JP; Linthicum LC
Hum Pathol; 1996 Dec; 27(12):1282-7. PubMed ID: 8958299
[TBL] [Abstract][Full Text] [Related]
20. Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.
Goicoechea M; Smith DM; Liu L; May S; Tenorio AR; Ignacio CC; Landay A; Haubrich R
J Infect Dis; 2006 Jul; 194(1):29-37. PubMed ID: 16741879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
